Midven News

26th October 2018 Birmingham, UK – Leading venture capital firm Midven is extending its team with the addition of two new analysts following a sustained period of growth and investment in the West Midlands. Following Midven’s landmark 25th year of investing in the region, graduates George Wood and Liam Bradley have joined the firm in […]

read more

7 September  2016 Two new faces have joined Birmingham-based venture capital specialists Midven’s growing team. Ben Reed, aged 21, and Joshua Rodger, aged 22, will support Midven’s investment management team in their roles as analysts.  Both of the new recruits have run social enterprises whilst at university through their involvement with Enactus. Enactus is an […]

read more

Antibody veteran joins new CEO as Crescendo redirects strategy to Oncology focus  Cambridge, UK: 17 November 2015 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics, today announced the appointment of Dr. Kevin Johnson as non-executive Chairman of the Board of Directors. The appointment is effective immediately. Dr. Johnson brings […]

read more

1 2 3 4
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now